SEC Form 4 · accession 0001070081-18-000023
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome B Zeldis
Director
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $18.01 | Jan 3, 2018 | A | 14,000 | A | — | Jan 2, 2028 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018.